A carregar...
Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation
Since cisplatin achieved clinical success, transition metal platinum (Pt) drugs have been effectively used for the treatment of cancer. Iridium (Ir) compounds are considered to be potential alternatives to Pt compounds, as they possess promising anticancer effects with minor side effects. Platelet a...
Na minha lista:
| Publicado no: | Int J Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5846649/ https://ncbi.nlm.nih.gov/pubmed/29436605 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijmm.2018.3472 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|